These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 35207243)

  • 1. Resolution of Overactive Bladder Symptoms After Anterior and Apical Prolapse Repair.
    Abrams M; Sears S; Wherley S; Rhodes S; Mangel J; Sheyn D
    Urogynecology (Phila); 2024 Mar; ():. PubMed ID: 38527970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome.
    Jhang JF; Jiang YH; Kuo HC
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse.
    Jankiewicz K; Bogusiewicz M; Nowakowski Ł; Rechberger T; Rogowski A; Miotla P
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence.
    Baessler K; Christmann-Schmid C; Maher C; Haya N; Crawford TJ; Brown J
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD013108. PubMed ID: 30121956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse.
    Kim MS; Lee GH; Na ED; Jang JH; Kim HC
    Obstet Gynecol Sci; 2016 May; 59(3):214-9. PubMed ID: 27200312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic organ prolapse and overactive bladder.
    de Boer TA; Salvatore S; Cardozo L; Chapple C; Kelleher C; van Kerrebroeck P; Kirby MG; Koelbl H; Espuna-Pons M; Milsom I; Tubaro A; Wagg A; Vierhout ME
    Neurourol Urodyn; 2010; 29(1):30-9. PubMed ID: 20025017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between overactive bladder and serum nerve growth factor concentrations in women with high-grade uterine prolapse.
    Yildiz Ş; Cengiz H; Kural A; Kaya C; Alay İ; Ekin M
    Int Urogynecol J; 2021 Feb; 32(2):345-351. PubMed ID: 32440884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019.
    Antunes-Lopes T; Cruz F
    Eur Urol Focus; 2019 May; 5(3):329-336. PubMed ID: 31231010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fundamentals of terminology in lower urinary tract function.
    Drake MJ
    Neurourol Urodyn; 2018 Aug; 37(S6):S13-S19. PubMed ID: 30614063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
    Sheng W; Zhang H; Ruth KH
    Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction.
    Bo K; Frawley HC; Haylen BT; Abramov Y; Almeida FG; Berghmans B; Bortolini M; Dumoulin C; Gomes M; McClurg D; Meijlink J; Shelly E; Trabuco E; Walker C; Wells A
    Int Urogynecol J; 2017 Feb; 28(2):191-213. PubMed ID: 27921161
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.